CELLABMED
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $29M
Investors
- 10
About CELLABMED
, Ltd., Ltd. develops advanced cancer therapies., Ltd. specializes in the development of innovative therapeutic solutions, primarily focusing on CAR-T cell therapy and antibody therapeutics. Their CAR-T cell therapy products are designed to treat rare and difficult-to-manage cancers, providing hope and treatment options for patients who previously had limited alternatives. Additionally, the company is committed to developing therapeutic antibodies that are effective across a range of diseases while minimizing side effects, thus addressing significant unmet medical needs in the healthcare market. These products are primarily targeted at oncologists, hospitals, and specialized clinics across international markets, with a particular emphasis on regions where advanced cancer treatments are needed most., Ltd. generates revenue through direct partnerships with healthcare providers and institutions, focusing on the commercialization of its flagship products, including its CAR-T therapies and therapeutic antibodies. The firm operates a business-to-business model, supplying advanced therapeutic solutions to hospitals and specialized cancer treatment centers, which integrate these innovative products into their treatment regimens. Pricing structures for these therapeutic offerings are built around the complexity and specialization of the treatments, typically involving case-by-case agreements based on patient needs and clinical use. The investment will support ongoing product improvements and potentially lead to the launch of new therapeutic offerings. Cellab Med also has plans to expand its market presence in regions that require advanced cancer treatments, as it seeks to reach more oncologists and specialized clinics globally.
Who invested in CELLABMED
10 investors across 2 rounds
See all investors in CELLABMED
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CELLABMED
Who invested in CELLABMED?
CELLABMED has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CELLABMED raised?
CELLABMED has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CELLABMED last raise money?
CELLABMED's most recent round on record is a Series B, in Nov 2021.
What does CELLABMED do?
CELLABMED is a pharmaceuticals company.
Where is CELLABMED headquartered?
CELLABMED is headquartered in Seoul, South Korea.
Which VCs invest in companies like CELLABMED?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at CELLABMED's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like CELLABMED? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.